Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection

被引：0
|
作者：
Petrova, N. V. [1 ,3 ]
Emelyanova, A. G. [1 ,3 ]
Tarasov, S. A. [1 ,3 ]
Glubokova, E. A. [2 ]
Kartashova, N. P. [2 ]
机构：
[1] Res Inst Gen Pathol & Pathophysiol, Moscow, Russia
[2] II Mechnikov Res Inst Vaccines & Sera, Moscow, Russia
[3] LLC MATERIA MEDICA HOLDING, Moscow, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2022年 / 174卷 / 02期
关键词：
influenza A infection; technologically processed antibodies; CD4; receptor; Ergoferon; Raphamin; EFFICACY; OSELTAMIVIR; ERGOFERON; SAFETY;
D O I：
10.1007/s10517-023-05683-8
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The antiviral activity of technologically processed antibodies to CD4 receptor was evaluated a model of sublethal A/California/04/2009 (H1N1)pdm09-induced influenza infection in female BALB/c mice. The technologically processed antibodies increased animal survival rate by 50% in comparison with the placebo group (p < 0.05), which correlated with significant inhibition of virus replication in the lungs (p < 0.05). The reference drug Tamiflu increased mouse survival rate (by 47%), decreased the virus titer in the lungs, and prevented body weight loss (p < 0.05 in comparison with the placebo group by all parameters). The intrinsic protective activity of technologically processed antibodies to CD4 receptor was demonstrated, which manifested in a decrease in viral load in the lower respiratory tract and an increase in the survival rate.
引用
收藏
页码：250 / 253
页数：4
相关论文
共 50 条
  • [41] The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice
    Kodama, Makoto
    Yoshida, Ryu
    Hasegawa, Takahiro
    Izawa, Masaaki
    Kitano, Mitsutaka
    Baba, Kaoru
    Noshi, Takeshi
    Seki, Takahiro
    Okazaki, Kenichi
    Tsuji, Masakatsu
    Kanazu, Takushi
    Kamimori, Hiroshi
    Homma, Tomoyuki
    Kobayashi, Masanori
    Sakoda, Yoshihiro
    Kida, Hiroshi
    Sato, Akihiko
    Yamano, Yoshinori
    ANTIVIRAL RESEARCH, 2014, 109 : 110 - 115
  • [42] The generation of CD4 T lymphocytes in patients with HIV infection
    Lane, HC
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1995, 9 (03) : 107 - 109
  • [43] Antiviral activity of novel oseltamivir derivatives against some influenza virus strains
    Kocik, Janusz
    Kolodziej, Marcin
    Joniec, Justyna
    Kwiatek, Magdalena
    Bartoszcze, Michal
    ACTA BIOCHIMICA POLONICA, 2014, 61 (03) : 509 - 513
  • [44] Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus
    Liu, Ge
    Xiong, Sheng
    Xiang, Yang-Fei
    Guo, Chao-Wan
    Ge, Feng
    Yang, Chong-Ren
    Zhang, Ying-Jun
    Wang, Yi-Fei
    Kitazato, Kaio
    ARCHIVES OF VIROLOGY, 2011, 156 (08) : 1359 - 1369
  • [45] Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses
    Park, Sehee
    Kim, Jin Il
    Lee, Ilseob
    Lee, Sangmoo
    Hwang, Min-Woong
    Bae, Joon-Yong
    Heo, Jun
    Kim, Donghwan
    Han, Sang-Zin
    Park, Man-Seong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (01) : 14 - 19
  • [46] Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera
    Denisova, G
    Lideman, L
    Spectorman, E
    Abulafia-Lapid, R
    Burke, M
    Yust, I
    Gershoni, JM
    MOLECULAR IMMUNOLOGY, 2003, 40 (05) : 231 - 239
  • [47] Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report
    Goto, Ryo
    Shiota, Seiji
    Kaimori, Ryo
    Horinouchi, Noboru
    Utsunomiya Nishimizu, Rie
    Yamamoto, Kyoko
    Miyazaki, Eishi
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [48] Type II PtdIns 4-kinase β associates with CD4-p56lck complex and is involved in CD4 receptor signaling
    Sinha, Ranjeet Kumar
    Bojjireddy, Naveen
    Kanojia, Deepak
    Subrahmanyam, Gosukonda
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 395 (1-2) : 231 - 239
  • [49] CD4 down-modulating compounds with potent anti-HIV activity
    Vermeire, K
    Schols, D
    Bell, TW
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1795 - 1803
  • [50] Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
    Yan, Hongxia
    Wu, Tong
    Chen, Yue
    Jin, Hongliang
    Li, Li
    Zhu, Yuanmei
    Chong, Huihui
    He, Yuxian
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
12345